According to an article in the Guardian, a review published in the British Medical Journal questions how effective Tamiflu really is. The problem is that Roche, the drug’s manufacturer, has not released sufficient information to be able to the judge the effectiveness of Tamiflu. Roche has made approximately £1.6bn this year.
[Professor] Freemantle said he saw “very little evidence to support the widespread use of oseltamivir [Tamiflu] in the otherwise healthy population who are developing signs of influenza-like illness.”
No comments:
Post a Comment